News

InteliChart Achieves Prestigious HITRUST Certification for Data Security

InteliChart Achieves Prestigious HITRUST Certification for Data Security

InteliChart Achieves HITRUST Certification

InteliChart has reached a significant milestone by securing the HITRUST Risk-based, 2-year (r2) Certification, demonstrating its unwavering dedication to robust cybersecurity and the protection of sensitive patient data. This is not just a certification; it is a testament to the company's commitment towards establishing the highest standards in information security.

The Importance of HITRUST Certification

The HITRUST r2 Certification is recognized globally as a pinnacle of information security assurance. It affirms that companies, like InteliChart, have implemented comprehensive security controls effectively. By achieving this certification, InteliChart makes it easier for potential clients to conduct due diligence, promoting a more efficient sales process and instilling confidence in its capacity to safeguard data. This not only enhances the reputation of the company but also builds trust among clients and partners.

InteliChart's Vision for Patient Data Protection

CEO Gary Hamilton emphasized the significance of this accomplishment by saying, "At InteliChart, our primary responsibility is the protection of patient data. Achieving the HITRUST r2 Certification showcases our commitment to the highest standards of data security. I'm incredibly proud of our team's collaborative effort that made this achievement possible, which further strengthens the trust our clients place in us."

Moving Towards Improved Cybersecurity Measures

InteliChart's attainment of the HITRUST r2 Certification ensures a robust framework for security that adheres to stringent regulatory standards. This not only provides clients with peace of mind regarding their data but also boosts operational efficiency. With a keen focus on providing secure and reliable patient engagement solutions, InteliChart allows healthcare providers to concentrate on delivering quality care rather than stressing over data security issues.

Expert Endorsements on HITRUST

Bimal Sheth, Executive Vice President at HITRUST, remarked on the importance of this certification by stating, "The HITRUST Assurance Program is recognized for its thoroughness, extensive control requirements, and committed oversight. The r2 Certification signifies that InteliChart is making proactive efforts towards cybersecurity and risk management."

Commitment to Data Protection Standards

Beyond the HITRUST r2 Certification, InteliChart also holds several notable certifications such as SOC 2, HITRUST Practitioner, HIPAA Security Certification, and NIST certifications. These recognitions reflect the company's ongoing commitment to maintaining superior data protection and privacy standards within the healthcare sector.

InteliChart's Contribution to Healthcare Technology

InteliChart's HITRUST r2 Certification underscores its proactive security measures which enhance its reputation as a reliable partner in the healthcare technology industry. Continuously adapting to the fast-paced digital landscape, the company remains devoted to upholding the highest levels of data protection for both healthcare providers and patients.

About InteliChart

InteliChart is renowned for its award-winning Healthy Outcomes patient-engagement platform, designed to help healthcare providers meet modern digital health expectations. Their diverse suite of solutions includes offerings such as Patient Portal, Family Portal, Patient Intake, Patient Notify, Patient Survey, Patient Schedule, Patient Activate, and Patient eHealth, making them a preferred partner for numerous EHR vendors and medical practices. With API integration spanning over 40 EHR systems, InteliChart continues to enable seamless access to its solutions, catering to the needs of over 80 million patient records.

Frequently Asked Questions

What is HITRUST Certification?

HITRUST Certification is a globally recognized standard that validates an organization's adherence to comprehensive information security requirements.

Why is HITRUST Certification important for InteliChart?

This certification enhances InteliChart's reputation by demonstrating its commitment to data security, easing the due diligence for prospective clients.

What does the HITRUST r2 Certification indicate?

The HITRUST r2 Certification indicates that InteliChart has implemented effective information security controls aligned with the highest standards.

What other certifications does InteliChart hold?

In addition to the HITRUST r2 Certification, InteliChart also holds SOC 2, HIPAA Security Certification, and NIST certifications.

What is the focus of InteliChart's patient engagement solutions?

InteliChart's solutions are designed to enhance patient engagement and facilitate healthcare providers in delivering quality care while ensuring robust data protection.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Empowering Women in Cannabis: Toronto's Radicle Femmes Event

Updated Category News Views 130

Empowerment Through Connection: Radicle Femmes Returns Radicle Femmes is set to make waves once again as it returns to Toronto, focusing on the empowerment, celebration, and advancement of women within the cannabis industry. This much-anticipated event will occur just ahead of International Women's Day, providing a platform for women and their allies to connect, share...

Continue Reading
Join the 2025 Tour For Life®: A Celebration of Animal Rescue

Updated Category News Views 450

Join the 2025 Tour For Life®: A Celebration of Animal Rescue North Shore Animal League America is gearing up for a remarkable journey with its 25th Annual Tour For Life®. This event is known as the world's largest cooperative pet adoption initiative, designed to shine a light on the importance of animal rescue and adoption. The tour is scheduled to traverse the country,...

Continue Reading
H.I.G. Capital Expands Portfolio with Kantar Media Acquisition

Updated Category News Views 198

H.I.G. Capital Completes Acquisition of Kantar Media H.I.G. Capital, a prestigious global alternative investment firm managing approximately $70 billion in capital, is thrilled to announce the successful acquisition of Kantar Media. This strategic move not only underscores H.I.G.'s commitment to growth but also establishes Kantar Media as a cornerstone in their expansive...

Continue Reading
Transforming $1000 Into a Fortune: Analog Devices Journey

Updated Category News Views 334

The Growth of $1000 in Analog Devices Stock Investing can sometimes feel like a gamble, but what if you made a decision 20 years ago that turned out to be incredibly rewarding? Let’s look at the investment story of Analog Devices (NASDAQ: ADI) and its transformative journey over two decades. Understanding Analog Devices Analog Devices is a leading global supplier of...

Continue Reading
Takeda and Keros Therapeutics Team Up for Cancer Treatment

Updated Category News Views 226

Takeda Partners with Keros Therapeutics for Elritercept Takeda has taken a significant step in strengthening its oncology pipeline through an exclusive licensing agreement with Keros Therapeutics, Inc. This collaboration focuses on furthering the development, manufacturing, and commercialization of elritercept, designed to tackle anemia linked to certain hematologic...

Continue Reading